{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T09:54:18Z","timestamp":1767174858948,"version":"build-2238731810"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,4,30]],"date-time":"2021-04-30T00:00:00Z","timestamp":1619740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,4,30]],"date-time":"2021-04-30T00:00:00Z","timestamp":1619740800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"MIUR-PRIN","award":["201528E7CM"],"award-info":[{"award-number":["201528E7CM"]}]},{"name":"INAIL-BRIC","award":["2019#23"],"award-info":[{"award-number":["2019#23"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Orthop Surg Res"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The long pentraxin PTX3 is generating great interest given the recent discovery of its involvement in bone metabolism. This study investigates the role of circulating PTX3 as a marker of bone-related phenotypes in patients with osteoporosis (OP) and osteoarthritis (OA).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      Serum PTX3 levels were determined using an enzyme-linked immunosorbent assay (ELISA) in a total of OP (\n                      <jats:italic>n<\/jats:italic>\n                      =32), OA (\n                      <jats:italic>n<\/jats:italic>\n                      =19) patients and healthy controls (CTR;\n                      <jats:italic>n<\/jats:italic>\n                      =25). ROC curve analysis was carried out to evaluate the potential of PTX3 for the diagnosis of bone-related phenotypes. In addition, the association between PTX3 serum levels and biochemical markers was estimated by Spearman correlation analysis.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Serum analysis reveals a statistically significant increase of PTX3 levels in OP and OA patients, compared to CTR subjects (****\n                      <jats:italic>p<\/jats:italic>\n                      &lt;\u20090.0001, ****\n                      <jats:italic>p<\/jats:italic>\n                      &lt;\u20090.0001). ROC curve of PTX3 levels exhibits an excellent sensitivity and specificity for OP and OA diseases (****\n                      <jats:italic>p<\/jats:italic>\n                      &lt;\u20090.0001 and ****\n                      <jats:italic>p<\/jats:italic>\n                      &lt;\u20090.0001, respectively). Moreover, serum PTX3 levels are positively associated with ALP (\n                      <jats:italic>r<\/jats:italic>\n                      = \u2212 0.5257,\n                      <jats:italic>p<\/jats:italic>\n                      = 0.0083) and PTH levels (\n                      <jats:italic>r<\/jats:italic>\n                      = 0.4704,\n                      <jats:italic>p<\/jats:italic>\n                      = 0.0203) in OP patients.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>These results confirm the pivotal role of PTX3 in bone metabolism and suggest its potential use as a predictor of OP and OA bone-related phenotypes.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13018-021-02440-3","type":"journal-article","created":{"date-parts":[[2021,4,30]],"date-time":"2021-04-30T07:03:03Z","timestamp":1619766183000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["The long pentraxin PTX3: a novel serum marker to improve the prediction of osteoporosis and osteoarthritis bone-related phenotypes"],"prefix":"10.1186","volume":"16","author":[{"given":"Virginia Veronica","family":"Visconti","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chiara","family":"Greggi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simona","family":"Fittipaldi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Donato","family":"Casamassima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariagrazia","family":"Tallarico","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco","family":"Romano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annalisa","family":"Botta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Umberto","family":"Tarantino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,4,30]]},"reference":[{"key":"2440_CR1","doi-asserted-by":"crossref","unstructured":"Porte R, Davoudian S, Asgari F, Parente R, Mantovani A, Garlanda C, et al. The long pentraxin PTX3 as a humoral innate immunity functional player and biomarker of infections and sepsis. Front Immunol. 2019; 10:794.","DOI":"10.3389\/fimmu.2019.00794"},{"key":"2440_CR2","doi-asserted-by":"crossref","unstructured":"Carrizzo A, Procaccini C, Lenzi P, Fusco C, Villa F, Migliarino S, et al. PTX3: An inflammatory protein modulating ultrastructure and bioenergetics of human endothelial cells. Immun Ageing. 2019;16:4.","DOI":"10.1186\/s12979-019-0144-0"},{"key":"2440_CR3","doi-asserted-by":"crossref","unstructured":"Daigo K, Inforzato A, Barajon I, Garlanda C, Bottazzi B, Meri S, et al. Pentraxins in the activation and regulation of innate immunity. Immunol Rev. 2016; 274(1):202\u201317.","DOI":"10.1111\/imr.12476"},{"key":"2440_CR4","doi-asserted-by":"crossref","unstructured":"Inforzato A, Doni A, Barajon I, Leone R, Garlanda C, Bottazzi B, et al. PTX3 as a paradigm for the interaction of pentraxins with the complement system. Semin Immunol. 2013;25(1):79\u201385.","DOI":"10.1016\/j.smim.2013.05.002"},{"key":"2440_CR5","doi-asserted-by":"crossref","unstructured":"Garlanda C, Jaillon S, Doni A, Bottazzi B, Mantovani A. PTX3, a humoral pattern recognition molecule at the interface between microbe and matrix recognition. Curr Opin Immunol. 2016;38:39\u201344.","DOI":"10.1016\/j.coi.2015.11.002"},{"key":"2440_CR6","doi-asserted-by":"crossref","unstructured":"Doni A, Stravalaci M, Inforzato A, Magrini E, Mantovani A, Garlanda C, et al. The long pentraxin PTX3 as a link between innate immunity, tissue remodeling, and cancer. Front Immunol. 2019;10:712.","DOI":"10.3389\/fimmu.2019.00712"},{"key":"2440_CR7","doi-asserted-by":"crossref","unstructured":"Doni A, Garlanda C, Mantovani A. PTX3 orchestrates tissue repair. Oncotarget. 2015;6(31):30435\u20136.","DOI":"10.18632\/oncotarget.5453"},{"key":"2440_CR8","doi-asserted-by":"crossref","unstructured":"Daigo K, Mantovani A, Bottazzi B. The yin-yang of long pentraxin PTX3 in inflammation and immunity. Immunol Lett. 2014;161(1):38\u201343.","DOI":"10.1016\/j.imlet.2014.04.012"},{"key":"2440_CR9","doi-asserted-by":"crossref","unstructured":"Tarantino U, Greggi C, Cariati I,Visconti VV, Gasparini E, Cateni M, Gasbarra E, Botta A, Salustri A, Scimeca M. The Role of PTX3 in Mineralization Processes and Aging-Related Bone Diseases. Front Immunol. 2021;11:622772.","DOI":"10.3389\/fimmu.2020.622772"},{"key":"2440_CR10","doi-asserted-by":"crossref","unstructured":"Bonfiglio R, Scimeca M, Urbano N, Bonanno E, Schillaci O. Breast microcalcifications: Biological and diagnostic perspectives. Futur Oncol. 2018;14(30):3097\u20139.","DOI":"10.2217\/fon-2018-0624"},{"key":"2440_CR11","doi-asserted-by":"publisher","first-page":"3125","DOI":"10.1038\/cddis.2017.514","volume":"8","author":"M Scimeca","year":"2017","unstructured":"Scimeca M, Salustri A, Bonanno E, Nardozi D, Rao C, Piccirilli E, et al. Impairment of PTX3 expression in osteoblasts: a key element for osteoporosis. Cell Death Dis. 2017;8:3125 [cited 2020 Sep 29].","journal-title":"Cell Death Dis"},{"key":"2440_CR12","doi-asserted-by":"crossref","unstructured":"Parente R, Sobacchi C, Bottazzi B, Mantovani A, Gr\u010devic D, Inforzato A. The long pentraxin PTX3 in bone homeostasis and pathology. Front Immunol. 2019;10:2628.","DOI":"10.3389\/fimmu.2019.02628"},{"key":"2440_CR13","doi-asserted-by":"crossref","unstructured":"Rezu\u0219 E, Cardoneanu A, Burlui A, Luca A, Codreanu C, Tamba BI, et al. The link between inflammaging and degenerative joint diseases. Int J Mol Sci. 2019;20(3):614.","DOI":"10.3390\/ijms20030614"},{"key":"2440_CR14","doi-asserted-by":"crossref","unstructured":"Ginaldi L, Di Benedetto MC, De Martinis M. Osteoporosis, inflammation and ageing. Immun Ageing. 2005;2:14.","DOI":"10.1186\/1742-4933-2-14"},{"key":"2440_CR15","doi-asserted-by":"crossref","unstructured":"Fischer J, Hans D, Lamy O, Marques-Vidal P, Vollenweider P, Aubry-Rozier B. \u201cinflammaging\u201d and bone in the OsteoLaus cohort. Immun Ageing. 2020;17:5.","DOI":"10.1186\/s12979-020-00177-x"},{"key":"2440_CR16","doi-asserted-by":"crossref","unstructured":"Ponnappan S, Ponnappan U. Aging and immune function: molecular mechanisms to interventions. Antioxidants Redox Signal. 2011;14(8):1551\u201385.","DOI":"10.1089\/ars.2010.3228"},{"key":"2440_CR17","doi-asserted-by":"crossref","unstructured":"Rea IM, Gibson DS, McGilligan V, McNerlan SE, Denis Alexander H, Ross OA. Age and age-related diseases: role of inflammation triggers and cytokines. Front Immunol. 2018;9:586.","DOI":"10.3389\/fimmu.2018.00586"},{"key":"2440_CR18","doi-asserted-by":"crossref","unstructured":"Lee EJ, Song DH, Kim YJ, Choi B, Chung YH, Kim SM, et al. PTX3 stimulates osteoclastogenesis by increasing osteoblast RANKL production. J Cell Physiol. 2014;229(11):1744\u201352.","DOI":"10.1002\/jcp.24626"},{"key":"2440_CR19","doi-asserted-by":"publisher","first-page":"6","DOI":"10.3389\/fimmu.2018.00417","volume":"9","author":"D Gr\u010devi\u0107","year":"2018","unstructured":"Gr\u010devi\u0107 D, Sironi M, Valentino S, Deban L, Cvija H, Inforzato A, et al. The long pentraxin 3 plays a role in bone turnover and repair. Front Immunol. 2018;9:6 [cited 2020 Sep 29].","journal-title":"Front Immunol"},{"key":"2440_CR20","doi-asserted-by":"crossref","unstructured":"Celi M, Rao C, Scialdoni A, Tempesta V, Gasbarra E, Pistillo P, et al. Bone mineral density evaluation in osteoporosis: why yes and why not? Aging Clin Exp Res. 2013;25 Suppl 1:S47-9.","DOI":"10.1007\/s40520-013-0074-1"},{"key":"2440_CR21","doi-asserted-by":"publisher","first-page":"1568","DOI":"10.1007\/s00330-004-2312-6","volume":"14","author":"M Kothari","year":"2004","unstructured":"Kothari M, Guermazi A, von Ingersleben G, Miaux Y, Sieffert M, Block JE, et al. Fixed-flexion radiography of the knee provides reproducible joint space width measurements in osteoarthritis. Eur Radiol. 2004;14:1568\u201373 [cited 2020 Dec 28].","journal-title":"Eur Radiol"},{"key":"2440_CR22","doi-asserted-by":"crossref","unstructured":"Kellgren JH, Lawrence JS. Radiological assessment of osteo-arthrosis. Ann Rheum Dis. Ann Rheum Dis. 1957;16 (4):494\u2013502.","DOI":"10.1136\/ard.16.4.494"},{"key":"2440_CR23","doi-asserted-by":"crossref","unstructured":"Tarantino U, Feola M, Celi M, Scimeca M. PTX3: a new mediator of bone metabolism and osteoporosis. Muscles Ligaments Tendons J. 2017;7(1):200\u20131.","DOI":"10.11138\/mltj\/2017.7.1.200"},{"key":"2440_CR24","doi-asserted-by":"crossref","unstructured":"Lee R, Ahn HR, Shin MH, Kim HN, Lee YH, Choi SW, et al. Association between plasma pentraxin 3 levels and bone mineral density in elderly Koreans: The Dong-gu Study. J Korean Med Sci. 2018;33 (11):1301-10.","DOI":"10.3346\/jkms.2018.33.e165"},{"key":"2440_CR25","doi-asserted-by":"crossref","unstructured":"Bultink IEM, Lems WF. Osteoarthritis and osteoporosis: what is the overlap? Curr Rheumatol Rep. 2013;15(5):328.","DOI":"10.1007\/s11926-013-0328-0"},{"key":"2440_CR26","doi-asserted-by":"crossref","unstructured":"Il IG, Kim MK. The relationship between osteoarthritis and osteoporosis. J Bone Miner. 2014;32(2):101\u20139.","DOI":"10.1007\/s00774-013-0531-0"},{"key":"2440_CR27","doi-asserted-by":"crossref","unstructured":"Greene MA, Loeser RF. Aging-related inflammation in osteoarthritis. Osteoarthr. Cartil. 2015;23(11):1966\u201371.","DOI":"10.1016\/j.joca.2015.01.008"},{"key":"2440_CR28","doi-asserted-by":"crossref","unstructured":"Garlanda C, Moalli F, Jaillon S, Inforzato A, Sironi M, Bottazzi B, et al. Pathogen recognition by the long pentraxin PTX3. J Biomed Biotechnol. 2011;2011:830421.","DOI":"10.1155\/2011\/830421"},{"key":"2440_CR29","doi-asserted-by":"crossref","unstructured":"Kucharzewska P, Christianson HC, Welch JE, Svensson KJ, Fredlund E, Ringn\u00e9r M, et al. Exosomes reflect the hypoxic status of glioma cells and mediate hypoxia-dependent activation of vascular cells during tumor development. Proc Natl Acad Sci U S A. 2013;110(18):7312\u20137.","DOI":"10.1073\/pnas.1220998110"},{"key":"2440_CR30","doi-asserted-by":"crossref","unstructured":"Kondo S, Ueno H, Hosoi H, Hashimoto J, Morizane C, Koizumi F, et al. Clinical impact of pentraxin family expression on prognosis of pancreatic carcinoma. Br J Cancer. 2013;109(3):739\u201346.","DOI":"10.1038\/bjc.2013.348"},{"key":"2440_CR31","doi-asserted-by":"crossref","unstructured":"Wills CA, Liu X, Chen L, Zhao Y, Dower CM, Sundstrom J, et al. Chemotherapy-induced upregulation of small extracellular vesicle-associated PTX3 accelerates breast cancer metastasis. Cancer Res. 2020;81(2):452-63.\u00a0","DOI":"10.1158\/0008-5472.CAN-20-1976"},{"key":"2440_CR32","doi-asserted-by":"crossref","unstructured":"Kunes P, Holubcova Z, Kolackova M, Krejsek J. Pentraxin 3(PTX 3): an endogenous modulator of the inflammatory response. Mediators Inflamm. 2012;2012:920517.","DOI":"10.1155\/2012\/920517"},{"key":"2440_CR33","doi-asserted-by":"crossref","unstructured":"Daigo K, Hamakubo T. Host-protective effect of circulating pentraxin 3 (PTX3) and complex formation with neutrophil extracellular traps. Front. Immunol. 2012;3:378.","DOI":"10.3389\/fimmu.2012.00378"},{"key":"2440_CR34","doi-asserted-by":"crossref","unstructured":"Rubino M, Kunderfranco P, Basso G, Greco CM, Pasqualini F, Serio S, et al. Epigenetic regulation of the extrinsic oncosuppressor PTX3 gene in inflammation and cancer. Oncoimmunology. 2017;6(7):e1333215.","DOI":"10.1080\/2162402X.2017.1333215"},{"key":"2440_CR35","doi-asserted-by":"crossref","unstructured":"Mukaiyama K, Kamimura M, Uchiyama S, Ikegami S, Nakamura Y, Kato H. Elevation of serum alkaline phosphatase (ALP) level in postmenopausal women is caused by high bone turnover. Aging Clin Exp Res. 2015;27(4):413\u20138.","DOI":"10.1007\/s40520-014-0296-x"},{"key":"2440_CR36","doi-asserted-by":"crossref","unstructured":"Tariq S, Tariq S, Lone KP, Khaliq S. Alkaline phosphatase is a predictor of Bone Mineral Density in postmenopausal females. Pakistan J Med Sci. 2019;35(3):749\u201353.","DOI":"10.12669\/pjms.35.3.188"},{"key":"2440_CR37","doi-asserted-by":"crossref","unstructured":"Fink HA, Litwack-Harrison S, Taylor BC, Bauer DC, Orwoll ES, Lee CG, et al. Clinical utility of routine laboratory testing to identify possible secondary causes in older men with osteoporosis: the Osteoporotic Fractures in Men (MrOS) Study. Osteoporos Int. 2016;27(1):331\u20138.","DOI":"10.1007\/s00198-015-3356-y"},{"key":"2440_CR38","doi-asserted-by":"crossref","unstructured":"Tarantino U, Iolascon G, Cianferotti L, Masi L, Marcucci G, Giusti F, et al. Clinical guidelines for the prevention and treatment of osteoporosis: summary statements and recommendations from the Italian Society for Orthopaedics and Traumatology. J Orthop Traumatol. 2017;18(Suppl 1):3\u201336.","DOI":"10.1007\/s10195-017-0474-7"},{"key":"2440_CR39","doi-asserted-by":"crossref","unstructured":"Rolighed L, Rejnmark L, Christiansen P. Bone involvement in primary hyperparathyroidism and changes after parathyroidectomy. Eur Endocrinol. 2014;10(1):84\u20137.","DOI":"10.17925\/EE.2014.10.01.84"},{"key":"2440_CR40","doi-asserted-by":"crossref","unstructured":"Huang JC, Sakata T, Pfleger LL, Bencsik M, Halloran BP, Bikle DD, et al. PTH Differentially Regulates Expression of RANKL and OPG. J Bone Miner Res. 2004;19(2):235\u201344.","DOI":"10.1359\/JBMR.0301226"}],"updated-by":[{"DOI":"10.1186\/s13018-021-02481-8","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2021,5,21]],"date-time":"2021-05-21T00:00:00Z","timestamp":1621555200000}}],"container-title":["Journal of Orthopaedic Surgery and Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13018-021-02440-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13018-021-02440-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13018-021-02440-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,30]],"date-time":"2021-07-30T12:19:38Z","timestamp":1627647578000},"score":1,"resource":{"primary":{"URL":"https:\/\/josr-online.biomedcentral.com\/articles\/10.1186\/s13018-021-02440-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,30]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["2440"],"URL":"https:\/\/doi.org\/10.1186\/s13018-021-02440-3","relation":{},"ISSN":["1749-799X"],"issn-type":[{"value":"1749-799X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4,30]]},"assertion":[{"value":"9 February 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 April 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 April 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 May 2021","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1186\/s13018-021-02481-8","URL":"https:\/\/doi.org\/10.1186\/s13018-021-02481-8","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by Medical Ethics Committee (Policlinico Tor Vergata, approval reference number #85\/12, June 2017), and informed consent was obtained from all individual participants included in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"288"}}